Agnovos Bioscience

Agnovos Bioscience company information, Employees & Contact Information

AgNovos Biocience is a developer of new therapies that leverage proprietary, bone-building technology and regenerative medicine to address unmet needs in the treatment of bone disease. The Company’s first product, the OSSURE Local Osteo-Enhancement Procedure (LOEP) kit has been evaluated in multiple clinical studies and is available in select markets. The Company has initiated RESTORE, a randomized, controlled, prospective, single-blinded, multi-national study designed to evaluate the impact of OSSURE LOEP on the risk of secondary hip fractures. RESTORE is one of the largest prospective studies ever conducted in orthopedic traumatology. The data generated will be critical to gaining access to new markets, including the U.S. and Japan. The Company has also developed the AGN1 LOEP SV kit investigational device intended to treat stable but painful vertebral compression fractures. That device has received both a Breakthrough Device designation and an Investigational Device Exemption (IDE) from the U.S. Food and Drug Administration. AgNovos Bioscience is privately held and has its corporate headquarters in New York City with manufacturing, research & development, and corporate support services located in Rockville, MD.
Looking for a particular Agnovos Bioscience employee's phone or email?

Agnovos Bioscience Questions

News

AGNOVO's Kaitlyn Thornton Brings Fresh Apples Backstage for Pop Culture Illumination - AndNowUKnow

AGNOVO's Kaitlyn Thornton Brings Fresh Apples Backstage for Pop Culture Illumination AndNowUKnow

AgNovos Bioscience Announces 150th Patient Enrolled in RESTORE Randomized, Controlled Trial - Business Wire

AgNovos Bioscience Announces 150th Patient Enrolled in RESTORE Randomized, Controlled Trial Business Wire

FDA OKs IDE trial of Agnovos Healthcare’s breakthrough spine device - BioWorld MedTech

FDA OKs IDE trial of Agnovos Healthcare’s breakthrough spine device BioWorld MedTech

FDA grants breakthrough status to heart failure, stent graft tech - MedTech Dive

FDA grants breakthrough status to heart failure, stent graft tech MedTech Dive

Top Agnovos Bioscience Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant